To allow a chance for survival, that source of infection had to go. Both lungs were removed and the patient switched to ECMO ...

Insmed (NasdaqGS:INSM) plans to present new clinical and preclinical research on treprostinil palmitil inhalation powder (TPIP) at PVRI 2026. The company will share Phase 3 trial design and Phase 2b ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...

The main pulmonary artery diameter, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in patients with connective tissue disease-associated PAH.

AI echocardiography using multimodal right ventricular assessment predicted mortality in pulmonary hypertension. Learn more.

Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...

A female patient in her 70s with a remote history of vocal cord paralysis was incidentally found to have a pulmonary artery aneurysm on a chest CT. Serial imaging performed over 3 years noted ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted premarket approval to Endotronix’s pulmonary artery sensor platform for remote management of ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello and welcome to this Medscape InDiscussion on pulmonary arterial hypertension (PAH). Our topic today is the very important ...

BOSTON -- Pulmonary artery denervation improved symptoms in pulmonary arterial hypertension (PAH), a clinical trial from China showed. The radiofrequency ablation procedure increased 6-minute walk ...